Piramal Pharma sees strong growth ahead on rising demand for cancer therapies
Published on: April 29, 2026, 4:27 p.m. | Source: The Hindu Business Line
Piramal Pharma expects strong earnings growth in 2–3 years, driven by cancer drugs, ADC therapies and recovery in global biotech funding and orders.
